BioVascular

BioVascular develops and commercializes drugs and devices for controlling platelet-mediated cardiovascular diseases. The company is committed to becoming a leading comprehensive specialty cardiovascular therapeutics company and leveraging corporate partnerships in markets with complex marketing barriers or combination technologies.